Transcriptomics

Dataset Information

Palbociclib-Mediated CDK4/6 Inhibition Reveals a Conserved Transcriptional Profile but Divergent Functional Outcomes in Colorectal Cancer


ABSTRACT: Background: Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors have demonstrated clinical efficacy in several malignancies; however, their role in colorectal cancer (CRC) remains unclear. This study aimed to characterize transcriptional and functional responses to CDK4/6 inhibition in CRC models using palbociclib. Methods: HCT116 and HT29 CRC cell lines were treated with palbociclib and assessed using cell viability assays, cell cycle and apoptosis analyses, RNA sequencing, gene set enrichment analysis (GSEA), leading-edge analysis, and protein assessment. Selected palbociclib-responsive genes were further evaluated using public tumor expression, survival, and drug-target databases. Results: Palbociclib reduced pRB levels in both models but produced distinct functional outcomes. HCT116 cells exhibited G₀/G₁ arrest and increased apoptosis, whereas HT29 cells showed limited cell-cycle and apoptotic responses. Transcriptomic profiling revealed a shared antiproliferative response together with divergent downstream programs. HCT116 cells showed prominent suppression of mitotic and cell-cycle pathways, whereas HT29 cells exhibited broader transcriptional response involving cell-cycle, stress-, immune-, and interferon-associated programs. Leading-edge analysis identified recurrent mitotic regulators, including PLK1, CDK1, and AURKA/B, in HCT116, whereas STAT1 and IFIT-family genes were recurrently represented in HT29. Total STAT1 protein abundance increased in HT29 cells; however, the pSTAT1/STAT1 ratio was reduced. Translational analyses revealed elevated tumor expression of several mitotic regulators and exploratory associations of higher PLK1, AURKA, and STAT1 expression with improved overall survival. PLK1 and AURKA were also identified as pharmacologically tractable kinase targets. Conclusions: Palbociclib induces a shared core antiproliferative transcriptional response in CRC models, while downstream transcriptional and phenotypic outcomes vary with cellular context. HCT116 cells showed coordinated suppression of mitotic programs together with cell-cycle arrest and apoptosis, whereas HT29 cells exhibited prominent stress- and interferon-associated transcriptional responses with limited corresponding phenotypic effects. These findings highlight the heterogeneity of responses to CDK4/6 inhibition in CRC and support further investigation of molecular features associated with differential response.

ORGANISM(S): Homo sapiens

PROVIDER: GSE354830 | GEO | 2026/11/19

REPOSITORIES: GEO